PA HB 1494

in committee

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, providing for over-the-counter availability of ivermectin.

Pennsylvania · 2025-2026 Regular Session (209th General Assembly) · lower

Quick answers

Did PA HB 1494 pass?

Not yet. PA HB 1494 is in committee as of 2025-05-21 and has not come to a final vote. Latest recorded action (2025-05-21): Referred to Health

What is PA HB 1494 about?

PA HB 1494 is a bill in the 2025-2026 Regular Session (209th General Assembly) titled “An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, providing for over-the-counter availability of ivermectin.”.

Who sponsors PA HB 1494?

Jacob Banta is the primary sponsor of PA HB 1494, joined by 10 cosponsors.

Introduced: —
Latest action: 2025-05-21 — Referred to Health
Bill type: bill
Last updated: —

Committees

Not provided by source.

Action timeline

2025-05-21
Referred to Health
referral-committee

Versions

Printer's No. PN1748Compare

Documents

Votes

Not provided by source.

Related bills

No related bills recorded for this bill.

Official source

https://www.palegis.us/legislation/bills/2025/hb1494

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:31:13.705233Z

Inspect retained evidence for changes recorded after evidence tracking began:

Source and document changes Status and relationship changes

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=PA&identifier=HB 1494. See the API docs or the MCP server for AI assistants.

Known limitations

Sponsor party and chamber affiliation are not yet captured by this API.
Committee referrals are not yet captured.

See the methodology page for data sources and limitations.